Parallel evolution of fluconazole resistance and tolerance in Candida glabrata
The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.
Abstract
Introduction: With the growing population of immunocompromised individuals, opportunistic fungal pathogens pose a global health threat. Candida species, particularly C. albicans and non-albicans Candida species such as C. glabrata, are the most prevalent pathogenic fungi. Azoles, especially fluconazole, are widely used therapeutic options. Objective: This study investigates how C. glabrata adapts to fluconazole, with a focus on understanding the factors regulating fluconazole tolerance and its relationship to resistance. Methods: This study compared the factors regulating fluconazole tolerance between C. albicans and C. glabrata. We analyzed the impact of temperature on fluconazole tolerance, and requirement of calcineurin and Hsp90 for maintenance of fluconazole tolerance. We isolated colonies from edge, inside and outside of inhibition zone in disk diffusion assays. And we exposed C. glabrata strain to high concentrations of fluconazole and investigated the mutants for development of fluconazole resistance and tolerance. Results: We found temperature modulated tolerance in the opposite way in C. albicans strain YJB-T1891 and C. glabrata strain CG4. Calcineurin and Hsp90 were required for maintenance of fluconazole tolerance in both species. Colonies from inside and outside of inhibition zones did not exhibited mutated phenotype, but colonies isolated from edge of inhibition zone exhibited diverse phenotype changes. Moreover, we discovered that high concentrations (16-128 μg/mL) of fluconazole induce the simultaneous but parallel development of tolerance and resistance in C. glabrata, unlike the sole development of tolerance in C. albicans. Conclusion: This study highlights that while tolerance to fluconazole is a common response in Candida species, the specific molecular mechanisms and evolutionary pathways that lead to this response vary between species. Our findings emphasize the importance of understanding the regulation of fluconazole tolerance in different Candida species to develop effective therapeutic strategies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“We have recently demonstrated that FLC tolerance exists in wild-type C. glabrata isolates and can be induced by exposure to FLC.”
From Uncovering the connection between tunicamycin-induced respiratory deficiency and reduced fluconazole tolerance in Candida glabrata (2025) · cites this paper as Zheng et al., 2024b
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tackling the emerging threat of antifungal resistance to human health
Fisher, M. C., Alastruey-Izquierdo, A., Berman, J., Bicanic, T., Bignell, E. M., Bowyer, P., Bromley, M., Brüggemann, R., Garber, G., Cornely, O. A., et al. (2022) · Nature Reviews Microbiology · doi:10.1038/s41579-022-00720-1 · Cited by 1,179
Azole Antifungal Resistance in Candida albicans and Emerging Non-albicans Candida Species
Whaley, S. G., Berkow, E. L., Rybak, J. M., Nishimoto, A. T., Barker, K. S., & Rogers, P. D. (2017) · Frontiers in Microbiology · doi:10.3389/fmicb.2016.02173 · Cited by 900
Hsp90 Potentiates the Rapid Evolution of New Traits: Drug Resistance in Diverse Fungi
Cowen, L. E., & Lindquist, S. (2005) · Science · doi:10.1126/science.1118370 · Cited by 698
Drug resistance and tolerance in fungi.
Berman, J., & Krysan, D. J. (2020) · Nature Reviews Microbiology · doi:10.1038/s41579-019-0322-2 · Cited by 642
Regulation of Ergosterol Biosynthesis in Saccharomyces cerevisiae
Jordá, T., & Puig, S. (2020) · Genes · doi:10.3390/genes11070795 · Cited by 489 · cited 1×
“…sterol, is an essential component of the plasma membrane, where it maintains the membrane ’ s structural integrity and fl uidity, enables the proper functioning of membrane-bound proteins, and facilitates the transmission of signaling molecules and various cellular processes (Jorda and Puig, 2020).”
BackgroundSanglard, D., Ischer, F., Marchetti, O., Entenza, J., & Bille, J. (2003) · Molecular Microbiology · doi:10.1046/j.1365-2958.2003.03495.x · Cited by 350
Sanglard, D., Ischer, F., Calabrese, D., Majcherczyk, P. A., & Bille, J. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.11.2753 · Cited by 337
Sanguinetti, M., Posteraro, B., Fiori, B., Ranno, S., Torelli, R., & Fadda, G. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.2.668-679.2005 · Cited by 319
Molecular mechanisms governing antifungal drug resistance
Lee, Y., Robbins, N., & Cowen, L. E. (2023) · npj Antimicrobials and Resistance · doi:10.1038/s44259-023-00007-2 · Cited by 304
Vermitsky, J.-P., & Edlind, T. D. (2004) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.48.10.3773-3781.2004 · Cited by 285
Research works printed but not linked: 11
- Bassetti, 2017, Intensive care medicine research agenda on invasive fungal infection in critically ill patients, Intensive Care Med., 43, 1225, 10.1007/s00134-017-4731-2 · DOI · Paper page
- Brunke, 2013, Two unlike cousins: Candida albicans and C. glabrata infection strategies, Cell Microbiol., 15, 701, 10.1111/cmi.12091 · DOI · Paper page
- Cowen, 2013, The fungal Achilles’ heel: targeting Hsp90 to cripple fungal pathogens, Curr. Opin. Microbiol., 16, 377, 10.1016/j.mib.2013.03.005 · DOI
- Day, 2013, Yeast petites and small colony variants: for everything there is a season, Adv. Appl. Microbiol., 85, 1, 10.1016/B978-0-12-407672-3.00001-0 · DOI
- Dujon, 2004, Genome evolution in yeasts, Nature, 430, 35, 10.1038/nature02579 · DOI · Paper page
- Malcolm, 2013, Endemic mycoses in immunocompromised hosts, Curr. Infect. Dis. Rep., 15, 536, 10.1007/s11908-013-0387-4 · DOI
- Pendleton, 2017, The significance of Candida in the human respiratory tract: our evolving understanding, Pathog. Dis., 75, 10.1093/femspd/ftx029 · DOI
- Sun, 2023, Aneuploidy enables cross-tolerance to unrelated antifungal drugs in Candida parapsilosis, Front. Microbiol., 14, 10.3389/fmicb.2023.1137083 · DOI
- Sun, 2023, Aneuploidy mediates rapid adaptation to a subinhibitory amount of fluconazole in candida albicans, Microbiol. Spectr., 11, e0301622, 10.1128/spectrum.03016-22 · DOI · Paper page
- Xu, 2021, Multifactorial mechanisms of tolerance to ketoconazole in candida albicans, Microbiol. Spectr., 9, 10.1128/Spectrum.00321-21 · DOI · Paper page
- Zheng, 2023, Chromosome 1 trisomy confers resistance to aureobasidin A in Candida albicans, Front. Microbiol., 14, 10.3389/fmicb.2023.1128160 · DOI
Cited by
Zheng, L., Dong, Y., Wang, J., Zhang, M., Xu, Y., Ma, L., & Guo, L. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1528341 · Cited by 2
“Disk diffusion assays were performed according to the protocols outlined in our previous studies (Guo et al., 2024; Zheng et al., 2024b; Zheng et al., 2024c), following the CLSI M44-A2 guidelines for antifungal disk diffusion susceptibility testing (CLSI, 2009), with minor modifications.”
Self-citation
Metadata
- Authors
- Zheng, L., Xu, Y., Wang, C., Dong, Y., & Guo, L.
- Venue
- Frontiers in Cellular and Infection Microbiology
- Publisher
- Frontiers Media SA
- Published
- 2024-09-27
- Volume
- 14
- ISSN
- 2235-2988
- Cited by
- 14
- References
- 20
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Parallel evolution of fluconazole resistance and tolerance in Candida glabrata. https://app.cochat.ai/papers/10.3389/fcimb.2024.1456907
- The paper
- Zheng, L., Xu, Y., Wang, C., Dong, Y., & Guo, L. (2024). Parallel evolution of fluconazole resistance and tolerance in Candida glabrata. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2024.1456907
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.